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requirement for establishing a permissive
epigenetic state at just a few key genes.
These studies illustrate that the regulation
of epigenetic changes should be consid-
ered in the context of the diversity of
development.REFERENCES
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Defining determinants of T cell fate is central to understanding adaptive immunity and the design of
effective vaccines. Tubo et al. demonstrate that intrinsic properties of T cell receptor signaling
dictate whether CD4 T cells adopt predominantly type 1 helper or follicular helper T cell phenotypes
in response to bacterial or viral infection.Naive CD4 T cells are multipotential
precursors, each bearing a unique T cell
antigen receptor (TCR). TCR recognition
of peptide-MHCII complexes (pMHCII)
expressed on antigen-presenting cells
(APCs) in T cell zones of secondary
lymphoid tissues initiates rapid clonal
expansion and differentiation of naive pre-
cursors into distinct effector subsets
specialized for defense against different
classes of microbes. A major early bifur-
cation in CD4 T cell responses determines
deployment of alternative types of helper
function: commitment to classical effector
T cells (such as Th1, Th2, or Th17), which
emigrate to nonlymphoid tissues to
regulate microbicidal actions of innate
immune cells at sites of infection, or to
T follicular helper (Tfh) cells, which traffic
to B cell follicles where they induce
germinal center responses that produce
antimicrobial antibodies (Crotty, 2011). In
addition to a dominant role for cytokines
in specifying these fates, mounting evi-
dence implicates an important role forTCR signal strength. In a tour de force of
cellular immunology, Tubo et al. (2013) in
this issue of Cell follow the fates of indi-
vidual CD4 T cell clones responding to
the same pMHCII ligand during infection
and find remarkably divergent con-
tributions to Tfh and non-Tfh effector
responses that correlate with intrinsic
characteristics of TCR signaling.
The rarity of naive clonal precursors
has, until recently, confounded efforts to
delineate natural antimicrobial T cell re-
sponses. With a frequency of about one
in a million for a given antigenic specificity
in the CD4 T cell repertoire, or 100 cells,
tracking responses of endogenous T cells
to a single peptide antigen has proved
challenging. Making the task more daunt-
ing is interclonal variation in TCR usage by
the few naive T cells that recognize the
same pMHCII complex. This raises
the possibility that clones activated by
the same microbial peptide might display
disparate responses that program alter-
native differentiative fates, even if theaveraged population response to that an-
tigen ismore stereotypical—albeit distinct
for different antigens. In the current
report, the authors find that, indeed, indi-
vidual CD4 T cell clones activated by
the same pMHCII complex via distinct
TCRs favor disparate programming for
Tfh and non-Tfh differentiation (Figure 1).
This supports models that predict a
component of predestination intrinsic to
the mechanics by which a T cell’s anti-
genic receptor engages its ligand and
reinvigorates longstanding interests in
understanding relationships between
TCR signaling thresholds and graded
responses.
The findings represent a culmination of
two decades of effort by the Jenkins lab to
understand CD4 T cell immunity the hard
way—not in a culture dish, but in the
tissues where they actually occur. Here,
they build on their pioneering pMHCII
tetramer-based enrichment techniques
to enumerate and phenotype rare anti-
gen-specific CD4 T cells (Moon et al.,l 153, May 9, 2013 ª2013 Elsevier Inc. 739
Figure 1. T Cell Signal Strength Determines
CD4 T Cell Fate
Tubo et al. (2013) demonstrate that antigen-
specific CD4 T cells responding to in vivo bacterial
or viral infection adopt one of three effector phe-
notypes, defined by high expression of Tbet and
IFNg (Th1), high expression of Bcl-6 and surface
CXCR5 (TFh), or coexpression of Tbet, Bcl-6,
PD-1, and high surface expression of CXCR5 (GC-
FTh). At the clonal level, CD4 T cells bearing TCRs
of sufficiently high aggregate t1/2 (ta) binding
kinetics to pMHCII adopt either a Th1 phenotype
essential for innate clearance of infection or
become Tfh cells that migrate to the germinal
center and mature into GC-FTh cells that regulate
humoral immunity. Naive T cells that bind pMHCII
weakly, yet sufficiently to initiate effector differen-
tiation, preferentially adopt a Th1 phenotype,
whereas stronger binders favor Tfh development.
In this model, Tfh development is predicted to
predominate at high antigen dose, whereas Th1
development predominates at low antigen dose.
The ability to alter CD4 T cell fate through tuning of
TCR signal strength may inform vaccine design
aimed at improving B cell affinity maturation and
antibody class switching.2007; Pepper et al., 2011). By coupling
this to elegant in vivo limiting dilution
adoptive transfers, Tubo et al. (2013)
fate-map single CD4 T cells from the
endogenous response to an infection by
attenuated Listeria monocytogenes (Lm)
strains engineered to express a variety
of model antigens. This intracellular bac-
terial pathogen is eliminated by coordi-740 Cell 153, May 9, 2013 ª2013 Elsevier Incnated CD4 and CD8 responses, the CD4
T cell arm of which is characterized by
parallel Th1-type effector and Tfh differ-
entiation that promotes enhanced micro-
bicidal actions of macrophages and B
cell help, respectively.
Results from the current study com-
plement and extend a remarkable ante-
cedent study that tracked the develop-
mental fate of single TCR transgenic
CD8 T cells following adoptive transfer.
Also employing Lm as a model pathogen,
Stemberger et al. (2007) unequivocally
demonstrated that a full range of effector
andmemory progeny arise from individual
naive precursors responding to infection
(Stemberger et al., 2007). Because their
study examined a single clonal specificity,
however, Stemberger et al. (2007) could
not exclude the possibility that alternative
TCR specificities might diverge from this
consistent effector/memory pattern. In
examining a range of clones reactive to
the same antigen and examining the
clonal response to multiple antigens,
Tubo et al. (2013) find a remarkable de-
gree of divergence in the contribution of
individual clones to the collective effector
response to that antigen. This implies that
different TCRs expressed by CD4 T cell
clones of the same pMHC specificity
have intrinsic tendencies to program their
progeny for differing ratios of mature sub-
sets—in this case, Th1, Tfh, and germinal
center-Tfh cells that develop in response
to Lm infection. Similar results are
obtained with infection by lymphocytic
choriomeningitis virus and are consistent
with results of Fazilleau et al. (2009), who
found that, within a polyclonal population
responding to antigen-specific immuniza-
tion, TCR repertoires of Tfh cells are the
most restricted. Thus, all else being equal,
variations in TCR signaling imparted by
the nature of the TCR’s interaction with
pMHCII complexes might dictate CD4
T cell fate.
So, what is it about the TCR-pMHCII
interaction that predicts whether a T cell
will favor a Th1 or Tfh fate? Dwell
time—that is, the effective half-life a
TCR binds its cognate pMHCII ligand so
as to fully engage the assembly of down-
stream signaling components above a
threshold, which has been calculated to
require on the order of 2 s. Recent exper-
iments that have tested models of TCR-
pMHC binding kinetics using systems.that more accurately reflect the confine-
ment of the TCR and its pMHC ligand to
opposing cell surfaces as occurs in
T cell-APC interactions support a variant
of the kinetic proofreading model of
T cell activation (Huang et al., 2010). In
this model, serial rebinding to pMHC
complexes favored by fast on-rates leads
to an aggregate half-life of TCR binding
(ta) that can initiate T cell activation
despite the brief t1/2 of individual TCR-
pMHC binding events.
Because they find that the balance of
effector cell subsets generated correlates
poorly with TCR affinity (KD) as measured
by pMHCII tetramer binding, Tubo et al.
(2013) examined ratios of Th1:Tfh:GC-
Tfh cells induced by Lm infection using a
set of transgenic TCR-pMHCII combina-
tions for which KD and ta values had
been previously determined (Govern
et al., 2010). Although the relationships
prove complex, the results demonstrate
much better correlation with aggregate
dwell time (ta) than the dissociation con-
stant (KD), making ta a better predictor of
CD4 T cell fate and providing support for
the notion that higher TCR signal strength
favors Tfh over Th1 development (Fazil-
leau et al., 2009). These findings establish
that variations in TCR signaling strength
can translate to divergent developmental
fates at the clonal level (Figure 1).
The findings and technical approaches
of Tubo et al. (2013) set the stage for
more mechanistic studies going forward.
What are the ‘‘instructions’’ received by
cells with the same TCR specificity that
are determined by signal magnitude, and
how does this bias between Th1 and Tfh
fates? TCR signaling strength positively
correlates with asymmetric cell division
in naive CD8 T cells that favors alternative
fates of daughter cells (King et al., 2012). If
CD4 T cells behave similarly, TCRs that
engage pMHCII complexes with greater
aggregate dwell times might favor asym-
metric cell divisions—with possible impli-
cations for Tfh versus non-Tfh effector
development. Could asymmetric cell divi-
sion partition the high-affinity IL-2 recep-
tor component (IL-2Ra, or CD25) between
daughter cells and account for its higher
expression by developing Th1 cells rather
than Tfh cells? And, given that activation
of STAT5 by IL-2 receptor signaling favors
expression of the transcription factor
Blimp-1, which favors the Th1 effector
program while repressing Bcl-6 (a
transcription factor essential for Tfh
development), could TCR signal strength
dictate differential programming through
this mechanism? What is the relationship,
if any, between TCR signal strength
and ICOS signaling, which also promotes
Tfh development? Finally, what are impli-
cations for the quality of the antibody
response controlled by Tfh cells or devel-
opment of CD4 T cell memory? In view of
data supporting development of CD4
memory T cells from Tfh precursors
(Choi et al., 2013; Pepper et al., 2011),
does initial TCR signaling serve to direct
alternative effector and memory CD4
T cell fates, and if so, might this translate
into memory populations with differing
recall characteristics? Clearly, much
work remains to be done. In the mean-time, this study highlights once more the
remarkable capacity of naive T cells to
integrate a diversity of input gradients
from both the TCR and non-TCR recep-
tors to direct alternative programs of
differentiation.REFERENCES
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Daily metabolic patterns are regulated in a circadian manner often via the hypothalamic axis.
Mukherji et al. now report a surprising role for commensal bacteria in the circadian regulation of
glucocorticoid production by intestinal epithelial cells.Glucocorticoid synthesis by intestinal
epithelial cells (IECs) is a well-known
example of a process regulated in a
circadian manner, with its production
being high during the active phase and
decreased during the resting period
(Asfeldt, 1971). Previous research has
mainly focused on the role of the hypo-
thalamic-pituitary-adrenal (HPA) axis in
controlling this daily pattern of production
(Kino, 2012). In this issue, Pierre Cham-
bon and colleagues (Mukherji et al.,
2013) take a decidedly different tack and
ask whether the gut microbiota mightplay a role in this process. The microbiota
encompass a diverse population of
bacteria, archaea, and fungi populating
many body sites of their multicellular
hosts (Lozupone et al., 2012). In mam-
mals, their largest numbers are found in
the gastrointestinal tract, with the highest
concentrations present in the large intes-
tine. These microbiota directly impact
the metabolic status of their hosts (Trem-
aroli and Ba¨ckhed, 2012; Turnbaugh
et al., 2006). For instance, the composi-
tion of the gut microbial communities
regulates the energy yield from food andmodulates the levels of host- and diet-
derived products directly controlling
metabolic pathways. Thus, not surpris-
ingly, the microbiota are considered a
key determinant of metabolic disease
progression. However, the systemic
impact of local (i.e., small and large intes-
tine) pathways that are activated during
symbiotic or abnormal host-microbiota
interactions remains largely undeter-
mined. Mukherji et al. unveil a surprising
new link between the modulation of the
circadian clock in IECs of the ileum by
the microbiota and systemic metabolism.l 153, May 9, 2013 ª2013 Elsevier Inc. 741
